Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Bonitar 400 mg Tablet
Manufacturer/Marketed By : Sun Pharmaceutical Industries Ltd
$31.17 $24.31
Bonitar 400 mg Tablet is a targeted therapy designed for the treatment of chronic myeloid leukemia (CML), particularly in patients who have shown resistance to previous treatments. The active ingredient,...
Bosutinib 400 mg
Active Pharmaceutical Ingredient
Bonitar 400 mg Tablet
$31.17
$24.31
Bonitar 400 mg Tablet is a targeted therapy designed for the treatment of chronic myeloid leukemia (CML), particularly in patients who have shown resistance to previous treatments. The active ingredient, Bosutinib, works by inhibiting specific proteins that promote the growth and proliferation of cancer cells, thereby helping to control the disease. It's crucial for patients to be aware of potential side effects, which may include diarrhea, nausea, and liver function changes, necessitating regular monitoring during treatment. Additionally, those with a history of liver disease or certain cardiovascular conditions should consult their healthcare provider before starting Bonitar. This medication is typically prescribed as part of a comprehensive treatment plan, tailored to each patient's unique needs. Patients are advised to adhere strictly to the dosage regimen to maximize the therapeutic benefits while minimizing risks. As with any anti-cancer therapy, ongoing communication with healthcare professionals is essential to ensure the best possible outcomes. Bonitar 400 mg Tablet represents a significant advancement in the fight against CML, offering hope for improved management of this challenging condition.
Active Pharmaceutical Ingredient
Uses
• Bonitar 400 mg tablet is primarily indicated for the treatment of chronic myeloid leukaemia (CML), a cancer that originates in the blood and bone marrow. Patients with CML may experience various symptoms, including fatigue, weakness, and night sweats. The medication works by targeting specific pathways involved in the growth of cancer cells, helping to manage the condition effectively. By using Bonitar 400 mg tablet, healthcare providers aim to improve the quality of life for those affected by this disease.
• In patients diagnosed with chronic myeloid leukaemia, Bonitar 400 mg tablet plays a crucial role in controlling the progression of the disease. It helps to reduce the number of cancerous cells in the bloodstream, which can alleviate symptoms associated with CML. Regular administration of Bonitar 400 mg tablet allows for better disease management, potentially leading to improved overall health outcomes. This targeted approach is essential for enhancing patient care in those living with CML.
• The use of Bonitar 400 mg tablet is significant in the long-term management of chronic myeloid leukaemia. It is often prescribed as part of a comprehensive treatment plan tailored to individual patient needs. By inhibiting the proliferation of leukaemic cells, Bonitar 400 mg tablet helps to stabilize the disease and prolong remission periods. This strategic use of the medication supports patients in maintaining their daily activities and overall well-being.
• Bonitar 400 mg tablet is an important therapeutic option for patients with chronic myeloid leukaemia, particularly in cases where other treatments may not be effective. Its mechanism of action specifically targets the underlying processes of CML, providing a targeted treatment solution. By incorporating Bonitar 400 mg tablet into their treatment regimen, patients may experience reduced symptoms and improved management of their condition. This makes it a valuable addition to the therapeutic arsenal for CML.
Benefits
Side effects of Bonitar 400 mg Tablet is used to treat a type of leukaemia known as chronic myeloid leukaemia (CML). It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the activity of a protein called BCR-ABL that causes the overgrowth of cancerous cells and chronic myeloid leukaemia. Bonitar 400 mg can affect the bone marrow and blood cells. By inhibiting the activity of BCR-ABL, the Bonitar 400 mg can help reduce the number of cancer cells in the body and improve the symptoms associated with the disease.
Side Effects
How Bonitar 400 mg Tablet works may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Nausea
• Vomiting
• Diarrhea
• Pain in the Stomach
• Blood in the stool or urine
• Chest pain









